{"id":"NCT02697773","sponsor":"Pfizer","briefTitle":"Efficacy and Safety of a Subcutaneous Tanezumab Titration Dosing Regimen in Subjects With Moderate to Severe Osteoarthritis of the Hip or Knee","officialTitle":"A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY OF THE ANALGESIC EFFICACY AND SAFETY OF A DOSE TITRATION REGIMEN FOR THE SUBCUTANEOUS ADMINISTRATION OF TANEZUMAB IN SUBJECTS WITH OSTEOARTHRITIS OF THE HIP OR KNEE","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-01-21","primaryCompletion":"2017-12-05","completion":"2018-05-14","firstPosted":"2016-03-03","resultsPosted":"2019-04-23","lastUpdate":"2021-05-03"},"enrollment":698,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Osteoarthritis, Knee","Osteoarthritis, Hip"],"interventions":[{"type":"OTHER","name":"Placebo","otherNames":[]},{"type":"BIOLOGICAL","name":"Tanezumab 2.5 mg","otherNames":[]},{"type":"BIOLOGICAL","name":"Tanezumab 2.5mg/5mg","otherNames":["Titration Arm"]}],"arms":[{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Tanezumab 2.5 mg","type":"EXPERIMENTAL"},{"label":"Tanezumab 2.5mg/5mg","type":"EXPERIMENTAL"}],"summary":"The primary purpose of this study is to evaluate the efficacy of a titration arm of tanezumab in which treatment is started at a lower dose (2.5 mg) and increased to a higher dose (5 mg) at Week 8, compared to giving 2 doses of tanezumab 2.5 mg or 2 doses of placebo. The study also evaluates the safety of the treatment regimens.","primaryOutcome":{"measure":"Change From Baseline in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Pain Subscale at Week 16","timeFrame":"Baseline, Week 16","effectByArm":[{"arm":"Placebo","deltaMin":-2.64,"sd":0.23},{"arm":"Tanezumab 2.5 mg","deltaMin":-3.23,"sd":0.23},{"arm":"Tanezumab 2.5/5 mg","deltaMin":-3.37,"sd":0.22}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0129"},{"comp":"OG000 vs OG002","p":"0.0023"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":12},"locations":{"siteCount":87,"countries":["United States","Canada","Puerto Rico"]},"refs":{"pmids":["38650049","38343426","37982583","37652258","37470295","37460782","36621827","36474952","36301512","35980115","35960482","35232805","35105318","34626502","33973384","32252976","31265100"],"seeAlso":["https://pmiform.com/clinical-trial-info-request?StudyID=A4091056"]},"adverseEventsSummary":{"seriousAny":{"events":9,"n":232},"commonTop":["Arthralgia","Nasopharyngitis","Musculoskeletal pain","Fall","Upper respiratory tract infection"]}}